Double-blind, placebo-controlled, proof-of-concept (POC) trial of ketamine therapy in treatment-resistant depression (TRD)
Ended Awarded Last action
- Contract number
- HHSN27100005
- Awardee
-
The General Hospital Corporation UEI FLJ7DQKLL226
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,021,575
Award facts
- Contract value 100% obligated
- $5,021,575.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Boston, MA 02199, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$110,792 | |
| Other Administrative Action | -$65,429 | |
| Exercise an Option | $288,473 | |
| Exercise an Option | $1,015,841 | |
| Exercise an Option | $426,752 | |
| Change Order | $325,706 | |
| Change Order | $135,426 | |
| Change Order | $0 | |
| Change Order | $0 | |
| Original award | $3,005,599 |
Quick answers
Who was awarded contract HHSN27100005?
HHSN27100005 was awarded to The General Hospital Corporation by National Institute on Drug Abuse (National Institutes of Health) on August 14, 2013.
How much is contract HHSN27100005 worth?
The government has obligated $5,021,575 on HHSN27100005.
Is contract HHSN27100005 an order under another contract?
Yes. HHSN27100005 is a delivery order under HHSN271201100006I, an indefinite delivery contract.
Was contract HHSN27100005 competed?
The extent of competition for HHSN27100005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award